The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
A vaccine to prevent cervical cancer is safe and effective in reducing cell changes, a new review has confirmed.
Study finds that young adults in the US who hadn’t been vaccinated were around 14 times more likely to have oral HPV infections than those who were vaccinated.
Around two-thirds of professionals who work in sexual health think the human papillomavirus (HPV) jab should be given to men who have sex with men
Around 20 per cent of girls from ethnic minority backgrounds are not being vaccinated against the HPV because they feel they don’t need to have it.
A single dose of Cervarix - a vaccine against two types of the human papillomavirus (HPV) - could be as effective in preventing infections as multiple doses.
A ‘next generation’ vaccine that protects against nine types of HPV may prevent even more cervical cancers than the current immunisation programme.
Boys should be vaccinated against a virus as well as girls to protect them from some types of cancer.
Genes that usually help the body fight off viral infections could actually be involved in the development of certain cancers.
The number of women under 30 diagnosed with cervical cancer will fall nearly two thirds by 2025, thanks to the HPV vaccine.